EarningsQ2 2024 Earnings Report

Mirum Pharmaceuticals (MIRM) Q2 2024 Earnings Report

0 Followers

MX:MIRM Q2 2024 EPS Results

Actual EPS-$9.44

Consensus EPS-$8.57

Beat/MissMissed by -$0.87

One Year Ago EPS-$35.23

Actual Revenue$1.41B

Expected Revenue$1.36B

Beat/MissBeat by +$51.69M

YoY Revenue Growth+107.68%

QuarterQ2 2024

Date08/07/2024

TimeAfter Close

Conference CallWednesday, August 7, 2024

MX:MIRM Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

MX:MIRM Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-8.90 / -	0.908	―
Aug 05, 2026	2026 (Q2)	-13.49 / -19.25	-2.179	-783.33% (-17.07)
May 06, 2026	2026 (Q1)	-6.63 / -243.90	-5.448	-4376.67% (-238.45)
Feb 25, 2026	2025 (Q4)	1.02 / -1.82	-8.899	79.59% (+7.08)
Nov 04, 2025	2025 (Q3)	-2.54 / 0.91	-5.448	116.67% (+6.36)
Aug 06, 2025	2025 (Q2)	-5.92 / -2.18	-9.444	76.92% (+7.26)
May 07, 2025	2025 (Q1)	-5.99 / -5.45	-9.807	44.44% (+4.36)
Feb 26, 2025	2024 (Q4)	-4.69 / -8.90	-11.441	22.22% (+2.54)
Nov 12, 2024	2024 (Q3)	-8.15 / -5.45	-10.352	47.37% (+4.90)
Aug 07, 2024	2024 (Q2)	-8.57 / -9.44	-35.232	73.20% (+25.79)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed